Agnieszka Boesen

Array ( [id] => 10381922 [patent_doc_number] => 20150266929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'VIRUS-LIKE PARTICLES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/703342 [patent_app_country] => US [patent_app_date] => 2015-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23597 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14703342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10450722 [patent_doc_number] => 20150335735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'PEPTIDE CARRIER FUSION PROTEINS AS ALLERGY VACCINES' [patent_app_type] => utility [patent_app_number] => 14/701848 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 29211 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15243445 [patent_doc_number] => 10507232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-17 [patent_title] => Materials and methods for the treatment of latent viral infection [patent_app_type] => utility [patent_app_number] => 15/300807 [patent_app_country] => US [patent_app_date] => 2015-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 10447 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14911057 [patent_doc_number] => 10426828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-01 [patent_title] => Compositions of multimeric-multiepitope influenza polypeptides and their production [patent_app_type] => utility [patent_app_number] => 15/300529 [patent_app_country] => US [patent_app_date] => 2015-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13988 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12253012 [patent_doc_number] => 09925142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment' [patent_app_type] => utility [patent_app_number] => 14/674063 [patent_app_country] => US [patent_app_date] => 2015-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15273 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14674063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11706252 [patent_doc_number] => 20170174751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 15/127404 [patent_app_country] => US [patent_app_date] => 2015-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33504 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367079 [patent_doc_number] => 20150252083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Strain-Independent Amplification of Pathogens and Vaccines Thereto' [patent_app_type] => utility [patent_app_number] => 14/659487 [patent_app_country] => US [patent_app_date] => 2015-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 31078 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14659487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298837 [patent_doc_number] => 20150183837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/621650 [patent_app_country] => US [patent_app_date] => 2015-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24696 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14621650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10381920 [patent_doc_number] => 20150266928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'METHOD OF PROTEIN EXTRACTION FROM CELLS' [patent_app_type] => utility [patent_app_number] => 14/598148 [patent_app_country] => US [patent_app_date] => 2015-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11006 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11198353 [patent_doc_number] => 09428556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Compositions and methods for the treatment or prevention of hepatitis B virus infection' [patent_app_type] => utility [patent_app_number] => 14/591592 [patent_app_country] => US [patent_app_date] => 2015-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 42 [patent_no_of_words] => 96366 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14591592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10458032 [patent_doc_number] => 20150343047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL DYSPLASIA' [patent_app_type] => utility [patent_app_number] => 14/579819 [patent_app_country] => US [patent_app_date] => 2014-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 37868 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10273935 [patent_doc_number] => 20150158933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'HIV Antigens and Antibodies and Compositions, Uses and Methods Thereof' [patent_app_type] => utility [patent_app_number] => 14/564075 [patent_app_country] => US [patent_app_date] => 2014-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 64516 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10201557 [patent_doc_number] => 20150086546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/559787 [patent_app_country] => US [patent_app_date] => 2014-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 35175 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14559787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10262787 [patent_doc_number] => 20150147784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'Reagents and Methods for Detecting Influenza Virus Proteins' [patent_app_type] => utility [patent_app_number] => 14/556415 [patent_app_country] => US [patent_app_date] => 2014-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6889 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14556415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17015395 [patent_doc_number] => 11085022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-10 [patent_title] => Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof [patent_app_type] => utility [patent_app_number] => 15/512726 [patent_app_country] => US [patent_app_date] => 2014-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 9088 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12099365 [patent_doc_number] => 09856453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject' [patent_app_type] => utility [patent_app_number] => 14/549296 [patent_app_country] => US [patent_app_date] => 2014-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 46 [patent_no_of_words] => 43933 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14549296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16697903 [patent_doc_number] => 10948494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Methods for enumeration of rare cells [patent_app_type] => utility [patent_app_number] => 15/033995 [patent_app_country] => US [patent_app_date] => 2014-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8542 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10290951 [patent_doc_number] => 20150175950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'METHOD AND APPARATUS FOR VIRUS AND VACCINE PRODUCTION' [patent_app_type] => utility [patent_app_number] => 14/528007 [patent_app_country] => US [patent_app_date] => 2014-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 26252 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14528007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10347950 [patent_doc_number] => 20150232955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'Method for Measuring Cell-Free Virus Particles From Dried Blood Spots' [patent_app_type] => utility [patent_app_number] => 14/518150 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7198 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838526 [patent_doc_number] => 20150030607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'INFLUENZA HEMAGGLUTININ-SPECIFIC MONOCLONAL ANTIBODIES FOR PREVENTING AND TREATING INFLUENZA VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 14/511013 [patent_app_country] => US [patent_app_date] => 2014-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7254 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511013 [rel_patent_id] =>[rel_patent_doc_number] =>)